Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

GREATER PRINCE WILLIAM AREA COMMUNITY HEALTH CENTER INC

NPI: 1366591562 · WOODBRIDGE, VA 22192 · Federally Qualified Health Center (FQHC) · NPI assigned 01/09/2007

$11.53M
Total Medicaid Paid
396,452
Total Claims
349,675
Beneficiaries
132
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMOORER, MELISSA (DIRECTOR OF REVENUE CYCLE)
Parent OrganizationGREATER PRINCE WILLIAM AREA COMMUNITY HEALTH CENTER INC
NPI Enumeration Date01/09/2007

Related Entities

Other providers sharing the same authorized official: MOORER, MELISSA

ProviderCityStateTotal Paid
GREATER PRINCE WILLIAM AREA COMMUNITY HEALTH CENTER INC MANASSAS VA $2.40M
GREATER PRINCE WILLIAM AREA COMMUNITY HEALTH CENTER INC DUMFRIES VA $794K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 15,808 $387K
2019 44,153 $865K
2020 50,475 $1.25M
2021 60,162 $1.53M
2022 76,583 $2.50M
2023 75,664 $2.43M
2024 73,607 $2.56M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 59,451 50,078 $3.74M
90837 Psychotherapy, 53 minutes with patient 21,196 10,764 $2.02M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 11,766 10,811 $922K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 7,873 7,722 $604K
59426 964 777 $576K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 8,067 7,648 $569K
59430 1,199 1,154 $263K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2,504 2,468 $191K
90670 4,987 4,843 $120K
90686 8,728 8,450 $109K
90677 1,437 1,401 $100K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 937 911 $95K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,097 1,085 $91K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 768 754 $89K
D2392 Resin-based composite - two surfaces, posterior, primary or permanent 1,529 1,031 $83K
D0150 Comprehensive oral evaluation - new or established patient 3,927 3,813 $81K
3008F 96,747 84,024 $77K
D1120 Prophylaxis - child 2,710 2,683 $68K
90834 Psychotherapy, 45 minutes with patient 980 752 $66K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 842 817 $66K
92551 6,817 6,672 $65K
D1206 Topical application of fluoride varnish 4,047 4,016 $65K
90697 1,698 1,646 $62K
99381 829 701 $60K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 671 650 $56K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 618 608 $55K
90460 Immunization administration through 18 years of age via any route, first or only component 18,312 17,702 $53K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3,869 2,789 $52K
D0120 Periodic oral evaluation - established patient 3,676 3,637 $51K
90651 1,087 1,077 $50K
90681 2,388 2,295 $49K
90715 1,570 1,511 $48K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 486 470 $46K
D1110 Prophylaxis - adult 1,676 1,649 $45K
90633 3,459 3,381 $45K
90710 1,215 1,185 $44K
G0467 Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit 2,680 2,266 $41K
99000 22,251 19,679 $39K
D0220 Intraoral - periapical first radiographic image 3,935 3,780 $32K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2,840 2,787 $31K
90648 2,989 2,907 $31K
D0210 Intraoral - complete series of radiographic images 1,079 756 $29K
D0230 Intraoral - periapical each additional radiographic image 3,467 2,104 $28K
99188 1,401 1,375 $28K
87428 918 865 $28K
90723 1,791 1,730 $27K
87807 1,989 1,868 $24K
90461 11,018 10,654 $24K
36415 Collection of venous blood by venipuncture 14,610 13,084 $22K
90734 617 610 $19K
99383 225 220 $19K
83036 Hemoglobin; glycosylated (A1C) 2,584 2,528 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,360 1,306 $17K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 5,544 5,269 $17K
D0274 Bitewings - four radiographic images 948 940 $15K
0012A 426 423 $14K
90716 614 603 $14K
99385 153 149 $14K
99384 137 134 $13K
90791 Psychiatric diagnostic evaluation 134 132 $13K
90750 109 102 $12K
90700 970 960 $12K
99173 5,119 5,024 $12K
90832 Psychotherapy, 30 minutes with patient 219 188 $11K
0011A 424 423 $11K
90792 Psychiatric diagnostic evaluation with medical services 72 61 $10K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 88 87 $9K
D2391 Resin-based composite - one surface, posterior, primary or permanent 416 264 $9K
99177 1,940 1,911 $8K
81025 1,090 1,053 $8K
76801 107 104 $7K
90707 437 427 $7K
90696 432 430 $7K
3078F 1,332 1,268 $6K
0071A 145 143 $6K
3074F 1,353 1,282 $5K
D2393 Resin-based composite - three surfaces, posterior, primary or permanent 75 62 $5K
0072A 131 129 $5K
97803 100 93 $5K
97802 56 52 $4K
0003A 117 117 $4K
D0330 Panoramic radiographic image 62 61 $4K
59425 18 12 $4K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 96 94 $4K
90698 179 178 $3K
0001A 72 72 $3K
D0140 Limited oral evaluation - problem focused 138 138 $3K
0002A 70 70 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 207 197 $2K
90744 168 168 $2K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 75 18 $2K
99386 18 17 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 159 145 $2K
81002 555 530 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes 64 15 $1K
3079F 265 257 $1K
90846 Family psychotherapy without the patient present, 50 minutes 16 13 $1K
82274 129 97 $1K
99382 12 12 $1K
92587 213 206 $916.81
90713 70 68 $770.57
90472 Immunization administration, each additional vaccine (list separately) 319 308 $430.18
90685 37 36 $405.28
3075F 50 47 $375.00
80061 Lipid panel 1,076 1,056 $307.97
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 115 29 $110.76
36416 1,225 1,199 $77.20
87481 65 65 $70.18
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 14 13 $35.09
97014 122 34 $29.06
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 56 55 $26.61
88141 53 52 $18.44
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 140 135 $4.14
J1050 Injection, medroxyprogesterone acetate, 1 mg 12 12 $3.50
84439 321 312 $0.00
D4910 87 87 $0.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 65 65 $0.00
91300 24 23 $0.00
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 37 28 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 53 53 $0.00
87150 12 12 $0.00
V5008 Hearing screening 100 100 $0.00
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 77 77 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 252 246 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 623 601 $0.00
D4355 31 31 $0.00
91307 201 180 $0.00
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 12 12 $0.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 77 77 $0.00
G0008 Administration of influenza virus vaccine 15 12 $0.00
81001 12 12 $0.00
85027 14 14 $0.00